Condition
Homocystine; Metabolic Disorder
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Not Yet Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06298292Not Yet Recruiting
Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies
NCT05679310Not ApplicableCompleted
Innovative Biotechnological Production of Antioxidant Products
NCT05011032Not ApplicableWithdrawnPrimary
Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of Pakistan
NCT03444155Not ApplicableCompleted
Natural Versus Synthetic Vitamin B Complexes in Human
NCT03489538Completed
Homocysteine After Laparoscopic Roux-enY Gastric Bypass
Showing all 5 trials